Prognostic and clinicopathological value of high expression of <scp>TIM</scp>‐3 in different cancer types: A meta‐analysis
Wenbo Xu(Fifth Affiliated Hospital of Zhengzhou University), Zhengjun Kang(Fifth Affiliated Hospital of Zhengzhou University), Lizhuan Zheng(Fifth Affiliated Hospital of Zhengzhou University), Feng Qi(Jiangsu Cancer Hospital), Donghai Hou(Hebei Medical University), Yi Liu(The University of Texas MD Anderson Cancer Center), Yinghao Zhang(Fifth Affiliated Hospital of Zhengzhou University), Ruidi Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 4
Related Papers
Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ
|Nature Communications|2022|68
ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population
|Journal of Experimental & Clinical Cancer Research|2017|54
<p>Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities</p>
|OncoTargets and Therapy|2019|39
IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma
|Frontiers in Oncology|2020|21
Lipid metabolism analysis in esophageal cancer and associated drug discovery
|Journal of Pharmaceutical Analysis|2023|20